Navigation Links
Damon Runyon Cancer Research Foundation grants prestigious awards to 20 top young scientists
Date:1/13/2014

o, California, is investigating tumor-initiating cells in pediatric glioblastoma, a type of brain tumor. This rare subpopulation of cells has the unique capacity to re-establish the tumor after therapy, and is therefore a critical therapeutic target. He is using a technique called mass cytometry to determine how these cells respond to communication signals from their environment. The goal of this work is to identify drugs that specifically kill tumor-initiating cells by blocking the signaling networks that sustain their survival.

Alexey A. Soshnev, MD, PhD [HHMI Fellow] with his sponsor C. David Allis, PhD, at The Rockefeller University, New York, New York, studies how genetic information is packaged in the nucleus and how such packaging is interpreted by the cellular machinery. Changes in nuclear architecture may simultaneously affect the function of thousands of genes and are a hallmark of cancer. This research focuses on a family of small nuclear proteins termed "linker histones," which are thought to orchestrate higher-order folding of DNA in the nucleus. Understanding the molecular connection between the nuclear architecture and gene regulation will shed new light on the processes underlying oncogenic transformation.

Rohith K. Srivas, PhD, with his sponsor Michael P. Snyder, PhD, at Stanford University, Stanford, California, is studying the changes in the composition and function of bacteria inhabiting the human gut (microbiome). The microbiome plays an extensive role in modulating host metabolism and inflammation, which when disrupted can lead to diseases such as cancer. By tracking changes in the gut microbiome of patients undergoing drastic weight loss, this research will map the dynamics of host-microbiome connections, potentially highlighting strategies for modifying the microbiome to treat metabolic disorders and reduce the risk of gastric and colon cancers.

Chenxi Tian, PhD, with her sponsor Richard O. Hynes, PhD, at Massachuse
'/>"/>

Contact: Yung S. Lie, Ph.D.
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related biology news :

1. Damon Runyon Cancer Research Foundation awards $3.6 M to 9 top young clinical investigators
2. Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists
3. Damon Runyon-Rachleff Innovation Awards granted for pioneering ideas in cancer research
4. Mechanism affecting risk of prostate cancer is found
5. LSUHSC research reveals structure of master regulator and new drug target for autism, cervical cancer
6. Cancer drug protects against diabetes
7. Researchers discover a tumor suppressor gene in a very aggressive lung cancer
8. Novel noninvasive therapy prevents breast cancer formation in mice
9. UTSW study identifies potential therapeutic target for incurable, rare type of soft-tissue cancer
10. International team completes systematic, genomic study of cervical cancer
11. Breast cancer patients experience fewer side effects from anticancer drug when receiving acupuncture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Genisphere announced Tom Bliss ... further develop Genisphere,s therapeutics capabilities and portfolio. Mr. Bliss ... much of the last 25 years in leadership positions ... Johnson & Johnson. Tom started his career in Investment ... Finance. He graduated from Dartmouth College with a BA ...
(Date:6/26/2015)... ATL Technology, LLC, a top provider of electromechanical ... use solutions, headquartered in Springville, Utah , ... California corporation with locations in Santa ... Rica ). This acquisition will incorporate MedConx,s ... ATL Technology,s existing facility in Costa Rica ...
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
Breaking Biology News(10 mins):Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2
... Va. The availability of new genome sequencing ... to test an intriguing hypothesis about how agricultures ... plant pathogens. Boris Vinatzer, assistant professor of ... College of Agriculture and Life Sciences, has received ...
... GAINESVILLE, Fla. Using the genetic equivalent of an ... the Earth endured a massive cooling period between 500 ... (Feb. 7) in the journal Nature, researchers from the ... and the biotechnology company DNA2.0 describe how they reconstructed ...
... YORK (FEBRUARY 7, 2008) Madagascars turtles and tortoises, ... will continue to crawl steadily toward extinction unless major ... by the Wildlife Conservation Society and other groups. ... capital city Antananarivo, said there is still hope to ...
Cached Biology News:Tomato pathogen genome may offer clues about bacterial evolution at dawn of agriculture 2Scientists rebuild ancient proteins to reveal primordial Earth's temperature 2Madagascar's tortoises are crawling toward extinction, groups say 2
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell ... next month on his first mission to the International ... from 8 to 9 a.m. EDT Tuesday, July 7. ... in Star City, Russia . The interviews ... NASA Television highlighting his mission training. To schedule ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
Breaking Biology Technology:Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... MacroChem,s,(OTC Bulletin Board: MACM), (http://www.macrochem.com ) President and ... Winter Discovery,Day Conference XV at the Princeton Club in ... scheduled to present at 11:30 AM EST., The ... special,presentations from emerging public company CEOs from a wide ...
... CME LLC ( http://www.CMELLC.com ),a leading provider ... today announced its new structure and management team,put ... organization, better suited,to address the educational needs of ... Warner assumes the role of senior vice,president and ...
... Dec. 4 Immtech Pharmaceuticals,Inc. (AMEX: IMM ... an exclusive,license to BioAlliance Pharma SA (Euronext Paris ... pafuramidine maleate (pafuramidine), in,Europe for the treatment of ... treatment of Human African trypanosomiasis, also known as,African ...
Cached Biology Technology:MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York 2MacroChem to Present at Equities Magazine Conference December 7, 2007 in New York 3CME LLC Restructures, Announces Its New Executive Management Team 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 2Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 3Immtech and BioAlliance Sign Licensing Agreement for Pafuramidine 4